We really thought we were passed this point but it’s time for a refresher course in glucose monitoring. Thanks to the coronavirus the FDA has been relaxing regulations on the usage of glucose monitoring in a hospital setting. The FDA has granted Livongo emergency use authorization to allow its glucose meter in a hospital. It has also granted this authorization to Dexcom and Abbott for their CGM systems.
As we noted just yesterday the coronavirus is breaking down barriers and telemedicine is huge beneficiary. Besides Dexcom, Abbott and Livongo nearly every glucose meter whether it is continuous or conventional . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.